Asian Institute of Medical Sciences

Background

Established in 2010, the Asian Institute of Medical Sciences (AIMS) is a super-specialty tertiary care hospital located in Faridabad, India. Accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and the National Accreditation Board for Testing and Calibration Laboratories (NABL), AIMS is dedicated to providing accessible, affordable, and high-quality healthcare services. The hospital offers a comprehensive range of preventive, diagnostic, therapeutic, rehabilitative, palliative, and supportive services under one roof, catering to the diverse medical needs of the community.

Key Strategic Focus

AIMS specializes in multiple centers of excellence, including:

Asian Cancer Centre: Comprehensive oncology services.

Asian Centre for Bone Marrow Transplant: Advanced hematology treatments.

Asian Heart Centre: Cardiac care and surgeries.

Asian Centre for Advanced Surgery: Specialized surgical procedures.

Asian Centre for Neurology and Neurosurgery: Neurological treatments.

Asian Centre for Urology and Kidney Transplant: Renal care services.

Asian Centre for Renal Diseases: Kidney-related treatments.

Asian Centre for Bone and Joints: Orthopedic services.

Asian Centre for Advanced Imaging: Diagnostic imaging services.

Asian Centre for Gastroenterology: Digestive system treatments.

Asian Centre for Mother and Child: Maternal and pediatric care.

Asian Centre for Bariatric & Metabolic Surgery: Weight loss surgeries.

Asian Centre for Aesthetic Surgery & Medicine: Cosmetic procedures.

Asian IVF Centre: Fertility treatments.

These centers are equipped with state-of-the-art technology and staffed by experienced medical professionals, ensuring comprehensive care across various specialties.

Financials and Funding

AIMS has secured a total funding of $21 million over two funding rounds. The most recent funding was raised on February 6, 2018, from a Series Unknown round, with CDC Group and OrbiMed as notable investors. The hospital's annual revenue is estimated between $200 million and $500 million.

Technological Platform and Innovation

AIMS is at the forefront of medical technology, being the first hospital in North India to deploy Varian’s Rapid Arc on a Trilogy system. The hospital is also equipped with advanced robotic systems capable of performing multidisciplinary robotic surgeries across all departments. Its operating theaters are well-equipped to support a wide range of procedures, and it features a state-of-the-art bone marrow transplant unit, representing a pinnacle of advanced medical care in India.

Leadership Team

Dr. Narendra Kumar Pandey: Founder, Chairman, and Managing Director. A Padma Shri awardee and recipient of the Dr. B. C. Roy Award, Dr. Pandey is renowned for his pioneering work in video-assisted thoracoscopic surgery.

Dr. Praveen Bansal: Director of Medical Oncology. With over 20 years of experience, Dr. Bansal specializes in oncology treatments.

Dr. Rajiv Kumar Sethia: Associate Director & Head of Urology & Kidney Transplant. Dr. Sethia brings over two decades of expertise in urology and renal transplant procedures.

Dr. Manish Nanda: Senior Consultant - Aesthetic & Reconstructive Surgery. Dr. Nanda has more than 20 years of experience in plastic and reconstructive surgery.

Dr. Amit Chaudhary: Senior Consultant & Head – Cardiothoracic and Vascular Surgery (CTVS). With 16+ years of experience, Dr. Chaudhary specializes in cardiac surgeries.

Competitor Profile

Market Insights and Dynamics

The Indian healthcare sector is experiencing rapid growth, driven by increasing demand for quality medical services, technological advancements, and a growing middle-class population. The market is characterized by intense competition among private healthcare providers striving to offer comprehensive and specialized services.

Competitor Analysis

AIMS faces competition from several prominent healthcare institutions:

Yashoda Hospitals: With a workforce of 10,000 to 50,000 employees and revenue between $100 million and $500 million, Yashoda Hospitals offers a wide range of medical services.

Global Health (Medanta): Employing approximately 10,500 staff, Medanta has raised $425.6 million in funding and reported revenues of $401.9 million.

Paras Hospitals: With a team of 1,000 to 5,000 employees and $42 million in funding, Paras Hospitals generates revenue between $25 million and $100 million.

Fortis Healthcare: Employing 23,400 individuals, Fortis Healthcare has secured $575 million in funding and reported revenues of $847.1 million.

These competitors offer similar multi-specialty services, making the healthcare market highly competitive.

Strategic Collaborations and Partnerships

In April 2016, AIMS expanded its reach by taking over the management of the 100-bedded Dwarkadas Jalan Memorial Hospital in Dhanbad, Jharkhand, with plans to increase its capacity to 250 beds. This strategic move aims to extend AIMS's high-quality healthcare services to a broader population.

Operational Insights

AIMS's strategic focus on establishing centers of excellence across various specialties positions it as a comprehensive healthcare provider. Its investment in advanced medical technologies and a team of experienced professionals enhances its competitive edge in the market.

Strategic Opportunities and Future Directions

AIMS is poised for growth through further expansion of its services and facilities. By leveraging its technological advancements and expertise, the hospital aims to cater to the increasing demand for specialized medical care in India. Potential collaborations and partnerships may also play a crucial role in its future development.